INDL vs. CURE
INDL (Direxion Daily India Bull 3x Shares) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both Leveraged Equities funds from Direxion - INDL tracks the Indus India Index (300%) while CURE tracks the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, INDL returned 0.22%/yr vs 13.49%/yr for CURE. At a 0.41 correlation, their price movements are largely independent. INDL charges 1.33%/yr vs 1.08%/yr for CURE.
Performance
INDL vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INDL achieves a -23.37% return, which is significantly lower than CURE's -7.96% return. Over the past 10 years, INDL has underperformed CURE with an annualized return of 0.22%, while CURE has yielded a comparatively higher 13.49% annualized return.
INDL
- 1D
- 2.23%
- 1M
- 0.60%
- YTD
- -23.37%
- 6M
- -20.84%
- 1Y
- -28.42%
- 3Y*
- -0.01%
- 5Y*
- -2.48%
- 10Y*
- 0.22%
CURE
- 1D
- -0.55%
- 1M
- 13.53%
- YTD
- -7.96%
- 6M
- -6.00%
- 1Y
- 26.46%
- 3Y*
- 3.05%
- 5Y*
- 1.51%
- 10Y*
- 13.49%
INDL vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
INDL Direxion Daily India Bull 3x Shares | -23.37% | -3.21% | 7.56% | 26.06% | -22.88% | 40.26% | -36.43% | 3.15% | -34.29% | 127.98% |
CURE Direxion Daily Healthcare Bull 3x Shares | -7.96% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between INDL and CURE is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.36 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.41 |
The correlation between INDL and CURE shifts across timeframes, from 0.26 (1 year) to 0.41 (all time), reflecting how their relationship changes across market environments.
INDL vs. CURE - Sectors Allocation Comparison
Sectors
INDL
CURE
Financial Services
-
Consumer Cyclical
-
Industrials
-
Energy
-
Basic Materials
-
Technology
-
Consumer Defensive
-
Healthcare
Communication Services
-
Utilities
-
Real Estate
-
Financial Services
INDL
CURE
-
Consumer Cyclical
INDL
CURE
-
Industrials
INDL
CURE
-
Energy
INDL
CURE
-
Basic Materials
INDL
CURE
-
Technology
INDL
CURE
-
Consumer Defensive
INDL
CURE
-
Healthcare
INDL
CURE
Communication Services
INDL
CURE
-
Utilities
INDL
CURE
-
Real Estate
INDL
CURE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INDL vs. CURE — Risk / Return Rank
INDL
CURE
INDL vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily India Bull 3x Shares (INDL) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INDL | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.56 | ||
| Sortino ratioReturn per unit of downside risk | -2.55 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.13 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 0.85 | -1.61 |
| Martin ratioReturn relative to average drawdown | -1.55 | 1.94 | -3.49 |
Loading charts...
Drawdowns
INDL vs. CURE - Drawdown Comparison
The maximum INDL drawdown since its inception was -95.67%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for INDL and CURE.
Loading charts...
Drawdown Indicators
| INDL | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.67% | -69.19% | -26.48% |
Max Drawdown (1Y)Largest decline over 1 year | -37.82% | -31.10% | -6.72% |
Max Drawdown (3Y)Largest decline over 3 years | -47.64% | -51.93% | +4.29% |
Max Drawdown (5Y)Largest decline over 5 years | -47.64% | -52.23% | +4.59% |
Max Drawdown (10Y)Largest decline over 10 years | -91.96% | -69.19% | -22.77% |
Current DrawdownCurrent decline from peak | -78.43% | -26.94% | -51.49% |
Average DrawdownAverage peak-to-trough decline | -66.36% | -18.16% | -48.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.35% | 13.71% | +4.64% |
Volatility
INDL vs. CURE - Volatility Comparison
The current volatility for Direxion Daily India Bull 3x Shares (INDL) is 8.12%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 14.30%. This indicates that INDL experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INDL | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.12% | 14.30% | -6.18% |
Volatility (6M)Calculated over the trailing 6-month period | 25.59% | 30.87% | -5.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.71% | 44.32% | -14.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.62% | 43.84% | -13.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 52.69% | 49.59% | +3.10% |
INDL vs. CURE - Expense Ratio Comparison
INDL has a 1.33% expense ratio, which is higher than CURE's 1.08% expense ratio.
Dividends
INDL vs. CURE - Dividend Comparison
INDL's dividend yield for the trailing twelve months is around 1.64%, more than CURE's 1.16% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.16% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
INDL Direxion Daily India Bull 3x Shares | 1.64% | 1.42% | 2.79% | 1.65% | 0.09% | 2.35% | 0.00% | 0.68% | 0.18% | 0.31% |
Frequently Asked Questions
INDL and CURE have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (14.30%) compared to INDL (8.12%). In terms of maximum drawdown, INDL dropped -95.67% vs CURE's -69.19%.
On 10-year performance, CURE leads with 13.49% vs 0.22% for INDL. On fees, CURE is cheaper at 1.08% per year. On volatility, INDL has been the lower-risk option at 8.12%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.49% return vs 0.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CURE is cheaper with a 1.08% expense ratio, compared with 1.33% for INDL.
INDL has the higher dividend yield at 1.64%, compared with 1.16% for CURE.
INDL tracks Indus India Index (300%), while CURE tracks Health Care Select Sector Index (300%). Their fees differ too: 1.33% for INDL and 1.08% for CURE.
CURE currently has the higher Sharpe Ratio (0.60 vs -0.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INDL and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer